Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients

Experimental and Molecular Pathology

Volumn 95, Issue 3, 2013, Pages 255-258

  Al Qahtani, Ahmed A ^a,d   Al Anazi, Mashael ^a   Abdo, Ayman A ^b,d   Sanai, Faisal M ^c,d   Al Hamoudi, Waleed ^b,d   Alswat, Khalid A ^b,d   Al Ashgar, Hamad I ^a   Khalaf, Nisreen ^a   Viswan, Nisha ^a   Al Ahdal, Mohammed N ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

HBV; HCC; MICA; Saudi Arabia; Single nucleotide polymorphism

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; INFECTION SENSITIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MHC CLASS I POLYPEPTIDE RELATED CHAIN A GENE; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIRUS CARRIER; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; GENETICS; HEPATITIS B VIRUS; LIVER NEOPLASMS; MULTICENTER STUDY; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

HLA ANTIGEN CLASS 1; MHC CLASS I-RELATED CHAIN A; VIRUS DNA;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SAUDI ARABIA;

EID: 84884911603     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.08.005     Document Type: Article

References (32)

1. Abdo A.A., et al. Saudi Gastroenterology Association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations. Ann Saudi Med. 2006, 26:261-265.
2. Aquino-Galvez A., et al. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum. Genet. 2009, 125:639-648.
3. Bauer S., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
4. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1956.
5. Bosch F.X., et al. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005, 9:191-211. (v).
6. Gong Z., et al. Association of MICA gene polymorphisms with liver fibrosis in schistosomiasis patients in the Dongting Lake region. Braz. J. Med. Biol. Res. 2012, 45:222-229.
7. Groh V., et al. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998, 279:1737-1740.
8. Groh V., et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6879-6884.
9. Groh V., et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
10. Guo X., et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011, 53:422-428.
11. Holdenrieder S., et al. Soluble MICA in malignant diseases. Int. J. Cancer 2006, 118:684-687.
12. Hu L., et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012, 55:1426-1431.
13. Jiang X., et al. Association of major histocompatibility complex class I chain-related gene A microsatellite polymorphism and hepatocellular carcinoma in South China Han population. Tissue Antigens 2011, 78:143-147.
14. Jinushi M., et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 2003, 104:354-361.
15. Kamatani Y., et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 2009, 41:591-595.
16. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2002, 2:395-403.
17. Karacki P.S., et al. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun. 2004, 5:261-266.
18. Kumar V., et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat. Genet. 2011, 43:455-458.
19. Kumar V., et al. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One 2012, 7:e44743.
20. Li K., et al. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol. Immunother. 2009, 58:641-652.
21. Lopez-Vazquez A., et al. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis. 2004, 189:957-963.
22. Mbarek H., et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 2011, 20:3884-3892.
23. Mizuki N., et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1298-1303.
24. Nuckel H., et al. The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 2010, 24:1152-1159.
25. Park Y., et al. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 2001, 24:33-38.
26. Popov E.A., et al. Immunogenetic HLA markers of chronic viral hepatitis. Ter. Arkh. 2005, 77:54-59.
27. Tamaki S., et al. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum. Immunol. 2008, 69:88-93.
28. Thio C.L., et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J. Virol. 2003, 77:12083-12087.
29. Woolley N., et al. Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population. Scand. J. Immunol. 2005, 61:51-56.
30. Wu Y.F., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J. Med. Virol. 2004, 72:17-25.
31. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 2003, 3:304-316.
32. Zwirner N.W., et al. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum. Immunol. 1999, 60:323-330.